Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.

Definitive Healthcare Corp.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

FRAMINGHAM, MASS., SEPT. 02, 2025 (GLOBE NEWSWIRE) -- DEFINITIVE HEALTHCARE CORP. (DEFINITIVE HEALTHCARE) (NASDAQ: DH), AN INDUSTRY LEADER IN HEALTHCARE COMMERCIAL INTELLIGENCE, TODAY ANNOUNCED THAT ITS CHIEF EXECUTIVE OFFICER, KEVIN COOP, AND CHIEF FINANCIAL OFFICER, CASEY HELLER, WILL PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE.

DEFINITIVE HEALTHCARE TO PRESENT AT THE MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE

FRAMINGHAM, MASS., JULY 24, 2025 (GLOBE NEWSWIRE) -- DEFINITIVE HEALTHCARE CORP. (DEFINITIVE HEALTHCARE) (NASDAQ: DH), AN INDUSTRY LEADER IN HEALTHCARE COMMERCIAL INTELLIGENCE, TODAY ANNOUNCED THAT IT WILL REPORT FINANCIAL RESULTS FOR ITS SECOND QUARTER ENDED JUNE 30, 2025, ON THURSDAY, AUGUST 7, 2025 AFTER MARKET CLOSE.

DEFINITIVE HEALTHCARE ANNOUNCES TIMING OF ITS SECOND QUARTER 2025 FINANCIAL RESULTS CONFERENCE CALL AND WEBCAST

FRAMINGHAM, MASS., JULY 01, 2025 (GLOBE NEWSWIRE) -- DEFINITIVE HEALTHCARE (NASDAQ: DH), AN INDUSTRY LEADER IN HEALTHCARE COMMERCIAL INTELLIGENCE, TODAY ANNOUNCED THAT IN CONNECTION WITH THE HIRING OF TWO SENIOR LEADERS, THE HUMAN CAPITAL MANAGEMENT AND COMPENSATION COMMITTEE (THE COMMITTEE) OF DEFINITIVE HEALTHCARE'S BOARD OF DIRECTORS GRANTED INDUCEMENT AWARDS. THE COMMITTEE GRANTED JEANNINE LOMBARDI, DEFINITIVE HEALTHCARE'S NEW CHIEF HUMAN RESOURCE OFFICER, AN INDUCEMENT AWARD CONSISTING OF 421,349 TIME-BASED RESTRICTED STOCK UNITS (RSUS), AND JONATHAN PARIS, DEFINITIVE HEALTHCARE'S NEW CHIEF LEGAL OFFICER, AN INDUCEMENT AWARD CONSISTING OF 421,349 TIME-BASED RSUS, EACH EFFECTIVE JULY 1, 2025. EACH OF THESE AWARDS WAS INDIVIDUALLY NEGOTIATED AND WAS GRANTED AS AN INDUCEMENT MATERIAL TO MS. LOMBARDI'S AND MR. PARIS'S RESPECTIVE COMMENCEMENT OF EMPLOYMENT WITH DEFINITIVE HEALTHCARE IN ACCORDANCE WITH NASDAQ LISTING RULE5635(C)(4).

DEFINITIVE HEALTHCARE CORP. REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

FRAMINGHAM, MASS., JUNE 03, 2025 (GLOBE NEWSWIRE) -- DEFINITIVE HEALTHCARE (NASDAQ: DH), AN INDUSTRY LEADER IN HEALTHCARE MARKET DATA AND ANALYTICS, TODAY ANNOUNCED THAT IN CONNECTION WITH THE HIRING OF A SENIOR LEADER, THAT THE HUMAN CAPITAL MANAGEMENT AND COMPENSATION COMMITTEE (THE COMMITTEE) OF DEFINITIVE HEALTHCARE'S BOARD OF DIRECTORS GRANTED AN INDUCEMENT AWARD.

FRAMINGHAM, MASS., MAY 08, 2025 (GLOBE NEWSWIRE) -- DEFINITIVE HEALTHCARE CORP. (DEFINITIVE HEALTHCARE OR THE COMPANY) (NASDAQ: DH), AN INDUSTRY LEADER IN HEALTHCARE COMMERCIAL INTELLIGENCE, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2025.

DEFINITIVE HEALTHCARE REPORTS FINANCIAL RESULTS FOR FIRST QUARTER FISCAL YEAR 2025

FRAMINGHAM, MASS., APRIL 24, 2025 (GLOBE NEWSWIRE) -- DEFINITIVE HEALTHCARE CORP. (DEFINITIVE HEALTHCARE) (NASDAQ: DH), AN INDUSTRY LEADER IN HEALTHCARE COMMERCIAL INTELLIGENCE, TODAY ANNOUNCED THAT IT WILL REPORT FINANCIAL RESULTS FOR ITS FIRST QUARTER ENDED MARCH 31, 2025, ON THURSDAY, MAY 8, 2025 AFTER MARKET CLOSE. THE COMPANY WILL HOST A CONFERENCE CALL AND WEBCAST AT 5:00 PM (ET) / 2:00 PM (PT) TO DISCUSS THE COMPANY'S FINANCIAL RESULTS.

DEFINITIVE HEALTHCARE ANNOUNCES TIMING OF ITS FIRST QUARTER 2025 FINANCIAL RESULTS CONFERENCE CALL AND WEBCAST

FRAMINGHAM, MASS., APRIL 04, 2025 (GLOBE NEWSWIRE) -- DEFINITIVE HEALTHCARE (NASDAQ: DH), AN INDUSTRY LEADER IN HEALTHCARE COMMERCIAL INTELLIGENCE, TODAY ANNOUNCED THAT IN CONNECTION WITH THE HIRING OF ONE SENIOR LEADER, THE HUMAN CAPITAL MANAGEMENT AND COMPENSATION COMMITTEE (THE COMMITTEE) OF DEFINITIVE HEALTHCARE'S BOARD OF DIRECTORS GRANTED INDUCEMENT AWARDS. THE COMMITTEE GRANTED JEFF MOYER, DEFINITIVE HEALTHCARE'S NEW SVP OF GROWTH AND SALES OPERATIONS, AN INDUCEMENT AWARD CONSISTING OF 364,432 TIME-BASED RESTRICTED STOCK UNITS (RSUS), EFFECTIVE APRIL 3, 2025. THESE AWARDS WERE INDIVIDUALLY NEGOTIATED AND GRANTED AS AN INDUCEMENT MATERIAL TO MR. MOYER'S RESPECTIVE COMMENCEMENT OF EMPLOYMENT WITH DEFINITIVE HEALTHCARE IN ACCORDANCE WITH NASDAQ LISTING RULE5635(C)(4).

FRAMINGHAM, MASS., MARCH 04, 2025 (GLOBE NEWSWIRE) -- DEFINITIVE HEALTHCARE (NASDAQ: DH), AN INDUSTRY LEADER IN HEALTHCARE COMMERCIAL INTELLIGENCE, TODAY ANNOUNCED THAT IN CONNECTION WITH THE HIRING OF TWO SENIOR LEADERS, THE HUMAN CAPITAL MANAGEMENT AND COMPENSATION COMMITTEE (THE COMMITTEE) OF DEFINITIVE HEALTHCARE'S BOARD OF DIRECTORS GRANTED INDUCEMENT AWARDS. THE COMMITTEE GRANTED KATE HASTINGS, DEFINITIVE HEALTHCARE'S NEW CHIEF CUSTOMER OFFICER AN INDUCEMENT AWARD CONSISTING OF 172,414 TIME-BASED RESTRICTED STOCK UNITS (RSUS) EFFECTIVE MARCH 3, 2025 AND GRANTED BENJAMIN GRABOSKE, DEFINITIVE HEALTHCARE'S NEW EVP, TECHNOLOGY, ENGINEERING AND CHIEF DATA OFFICER AN INDUCEMENT AWARD CONSISTING OF 1,018,330 TIME-BASED RSUS, EFFECTIVE MARCH 3, 2025. EACH OF THESE AWARDS WAS INDIVIDUALLY NEGOTIATED AND WAS GRANTED AS AN INDUCEMENT MATERIAL TO MS. HASTINGS' AND MR. GRABOSKE'S RESPECTIVE COMMENCEMENT OF EMPLOYMENT WITH DEFINITIVE HEALTHCARE IN ACCORDANCE WITH NASDAQ LISTING RULE5635(C)(4).

FRAMINGHAM, MASS., FEB. 27, 2025 (GLOBE NEWSWIRE) -- DEFINITIVE HEALTHCARE CORP. (DEFINITIVE HEALTHCARE OR THE COMPANY) (NASDAQ: DH), AN INDUSTRY LEADER IN HEALTHCARE COMMERCIAL INTELLIGENCE, TODAY ANNOUNCED FINANCIAL RESULTS FOR THE QUARTER AND FULL YEAR ENDED DECEMBER 31, 2024.

DEFINITIVE HEALTHCARE REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL FISCAL YEAR 2024

FRAMINGHAM, MASS., FEB. 25, 2025 (GLOBE NEWSWIRE) -- DEFINITIVE HEALTHCARE CORP. (DEFINITIVE HEALTHCARE) (NASDAQ: DH), AN INDUSTRY LEADER IN HEALTHCARE COMMERCIAL INTELLIGENCE, TODAY ANNOUNCED THAT ITS CHIEF EXECUTIVE OFFICER, KEVIN COOP, AND ITS CHIEF FINANCIAL OFFICER, RICK BOOTH, WILL PRESENT AT THE RAYMOND JAMES 2025 INSTITUTIONAL INVESTORS CONFERENCE.

Definitive Healthcare Corp.

DH

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Definitive Healthcare Corp.

DH.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

DH